IRIS
LUISETTI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.035
AS - Asia 4.500
EU - Europa 3.910
SA - Sud America 506
AF - Africa 82
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 15.074
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.928
CN - Cina 2.648
SG - Singapore 942
IE - Irlanda 923
UA - Ucraina 772
DE - Germania 493
HK - Hong Kong 486
FI - Finlandia 476
BR - Brasile 405
RU - Federazione Russa 376
SE - Svezia 266
GB - Regno Unito 228
IT - Italia 143
VN - Vietnam 120
FR - Francia 59
CA - Canada 58
IN - India 43
AR - Argentina 36
MX - Messico 35
JP - Giappone 34
BE - Belgio 33
AU - Australia 32
IR - Iran 26
ZA - Sudafrica 26
BD - Bangladesh 24
IQ - Iraq 23
PT - Portogallo 23
EC - Ecuador 21
NL - Olanda 21
PK - Pakistan 20
PL - Polonia 18
ES - Italia 17
VE - Venezuela 17
TR - Turchia 15
CL - Cile 13
KR - Corea 13
AT - Austria 12
TW - Taiwan 12
EG - Egitto 11
IL - Israele 11
CZ - Repubblica Ceca 10
ID - Indonesia 10
KE - Kenya 10
LT - Lituania 10
SA - Arabia Saudita 8
JO - Giordania 7
KZ - Kazakistan 7
MA - Marocco 7
PH - Filippine 7
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
EU - Europa 5
LB - Libano 5
PY - Paraguay 5
TH - Thailandia 5
AL - Albania 4
CH - Svizzera 4
CO - Colombia 4
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
LV - Lettonia 4
MU - Mauritius 4
NG - Nigeria 4
OM - Oman 4
TN - Tunisia 4
MY - Malesia 3
NZ - Nuova Zelanda 3
UZ - Uzbekistan 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
JM - Giamaica 2
MM - Myanmar 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 15.065
Salva come PNG Salva come JPEG
Città #
Jacksonville 954
Chandler 927
Dublin 922
Nanjing 641
Hong Kong 474
Ashburn 426
Dallas 376
Beijing 369
Singapore 361
Boardman 306
Nanchang 231
Princeton 199
Lawrence 192
Shenyang 192
Wilmington 170
Hebei 163
Changsha 158
Jiaxing 148
Ann Arbor 147
Los Angeles 131
Hangzhou 104
Medford 101
Helsinki 93
Tianjin 91
Shanghai 76
Moscow 75
Redondo Beach 70
Buffalo 62
New York 60
Woodbridge 52
Munich 46
Ho Chi Minh City 45
Milan 43
São Paulo 38
Houston 37
Norwalk 37
The Dalles 36
Brussels 31
Falls Church 28
Kunming 27
Seattle 27
Hanoi 26
Piscataway 26
Fairfield 25
Tokyo 25
Washington 25
Verona 23
Brooklyn 21
Des Moines 20
Dearborn 19
Denver 19
Santa Clara 19
Stockholm 19
Chicago 18
Phoenix 18
Toronto 18
Atlanta 17
London 17
Tappahannock 17
Warsaw 17
Zhengzhou 16
Boston 15
Rio de Janeiro 15
Johannesburg 14
Montreal 14
San Francisco 14
Columbus 13
Turku 13
Chennai 12
Jinan 12
Manchester 12
Mexico City 12
Orem 12
Coimbra 11
Guangzhou 11
Rome 11
Baghdad 10
Changchun 10
Frankfurt am Main 10
Fuzhou 10
Pavia 10
Brisbane 9
Falkenstein 9
Jerusalem 9
Karachi 9
Belo Horizonte 8
Brasília 8
Lanzhou 8
Nairobi 8
Quito 8
Southwark 8
Vienna 8
Amsterdam 7
Auburn Hills 7
Melbourne 7
Ningbo 7
Nuremberg 7
Orange 7
Poplar 7
Querétaro 7
Totale 9.460
Salva come PNG Salva come JPEG
Nome #
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. 498
Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. 226
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 155
Abnormalities of Esophageal Motor Activity Are Highly Prevalent in Lung Transplanted Patients 142
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 141
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis. 131
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 130
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 130
Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency. 125
Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products 123
Familial elevation of serum angiotensin converting enzyme activity. 121
Advances in proteomic techniques for biomarker discovery in COPD 121
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles. 119
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 117
Assessment and management of pulmonary alveolar proteinosis in a reference center. 115
A national program for detection of alpha 1-antitrypsin deficiency in Italy. Gruppo I.D.A. 113
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and Italy. 110
Some properties of the alkaline proteinase from Aspergillus melleus. 106
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar Proteinosis 105
HLA markers in sarcoidosis. 104
A novel pharmacological approach for paraquat poisoning in rat and A549 cell line using ambroxol, a lung surfactant synthesis inducer. 104
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 104
Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study. 103
Studies of MR 889, a new synthetic proteinase inhibitor. 102
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 102
A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. 101
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene. 100
Ambroxol and pulmonary toxicity induced by antineoplastic drugs. 100
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. 100
The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? 100
alpha 1-antitrypsin TAQ I polymorphism and alpha 1-antichymotrypsin mutations in patients with obstructive pulmonary disease. 99
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 98
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 97
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001. 97
C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. 96
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 95
Alpha-1 antitrypsin deficiency: from Italy to the world. 94
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 93
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 93
α₁-Antitrypsin level and pheno/genotypes 93
The cystic fibrosis gene is not likely to be involved in chronic obstructive pulmonary disease. 92
Identification and characterisation of eight novel SERPINA1 null mutations. 92
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 91
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 91
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. 90
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells. 90
Association between markers of emphysema and more severe chronic obstructive pulmonary disease. 89
Incomplete expression of epithelial-mesenchymal transition markers in idiopathic pulmonary fibrosis. 89
Protease-antiprotease imbalance: local evaluation with bronchoalveolar lavage. 89
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. 88
Complement receptor 1 gene polymorphisms in sarcoidosis. 88
The Hermansky-Pudlak syndrome. A case with macrophage-neutrophil alveolitis. 88
A novel method for rapid genotypic identification of alpha 1-antitrypsin variants. 88
[American Thoracic Society/European Respiratory Society Statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency]. 88
Mechanisms of lung injury in cystic fibrosis. 87
Bioavailability of isoniazid, rifampicin and pyrazinamide (in free combination or fixed-triple formulation) in intermittent antituberculous chemotherapy. 87
Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease. 87
Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. 85
Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients. 85
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. 85
Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. 85
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 84
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 84
On the activity of MR 889, a new synthetic proteinase inhibitor. 81
Surfactant apoprotein A modulates interleukin-8 and monocyte chemotactic peptide-1 production 80
The Rapid FEV(1) Decline in Chronic Obstructive Pulmonary Disease Is Associated with Predominant Emphysema: A Longitudinal Study. 80
COPD: no gene left unturned 80
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. 80
Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study. 79
Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis. 79
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 79
Alpha 1-antitrypsin variants produced by recombinant DNA: differences in elastase inhibitory activity and resistance to oxidant agents. 78
Urinary desmosine excretion in acute exacerbations of COPD: a preliminary report. 77
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 77
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 77
Micellar Electrokinetic Chromatography with Laser Induced Detection and liquid chromatography tandem mass-spectrometry-based desmosine assays in urine of patients with Chronic Obstructive Pulmonary Disease: A comparative analysis. 77
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 77
HLA and sarcoidosis: new pathogenetic insights. 76
Biochemical and functional markers of lung damage after bleomycin treatment. 76
Interactions of P 1507, a new antioxidant agent, with phagocyte functions. 75
High performance capillary electrophoresis in the study of proteinase activity and of markers of lung destruction. 75
HLA Class I, II and III polymorphisms in sarcoidosis. 74
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 74
Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. 73
In Lysinuric Protein Intolerance system y+L activity is defective in monocytes and in GM-CSF-differentiated macrophages. 73
Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. 73
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. 72
Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. 72
Lung cancer in young adults. 72
You may say that I ain't free--but it don't worry me. 72
Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics. 72
Secondary outputs of alpha1-antitrypsin deficiency targeted detection programme. 71
Introduction: the history of the Alpha One International Registry (A.I.R.). 71
Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose. 71
Report of one case of familial sarcoidosis. 71
Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. 71
Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. 71
Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013. 71
Mapping the activities of secretory leukoprotease inhibitor. 70
Sarcoidosis of the thyroid: report of a case and a review of the literature. 70
Totale 9.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.959
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021898 0 0 0 0 0 182 11 220 38 215 191 41
2021/2022727 18 5 5 16 17 26 22 60 49 10 126 373
2022/20232.658 284 184 19 225 319 276 0 153 1.061 22 71 44
2023/2024955 102 180 43 67 109 199 14 50 8 68 73 42
2024/20252.422 80 225 70 121 51 89 83 249 559 83 244 568
2025/20263.007 366 379 710 647 632 273 0 0 0 0 0 0
Totale 15.154